scholarly journals Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study

2019 ◽  
Vol 30 ◽  
pp. v143-v144 ◽  
Author(s):  
F. Barlesi ◽  
D.-W. Kim ◽  
E.M. Bertino ◽  
M.J. van den Bent ◽  
H. Wakelee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Leptomeningeal Metastases ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Alk Positive ◽  
Nsclc Patients

scholarly journals Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study ( LOGIK1101 )

2020 ◽  
Vol 25 (12) ◽  
Author(s):  
Kaname Nosaki ◽  
Takeharu Yamanaka ◽  
Akinobu Hamada ◽  
Yoshimasa Shiraishi ◽  
Taishi Harada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Leptomeningeal Metastases ◽  
Small Cell Lung

scholarly journals MA21.05 Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer

2019 ◽  
Vol 14 (10) ◽  
pp. S336
Author(s):  
S. Watanabe ◽  
N. Matsumoto ◽  
J. Koshio ◽  
A. Ishida ◽  
T. Tanaka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive

scholarly journals Results of a GlobaL Phase II Study with Crizotinib in Advanced ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)

2012 ◽  
Vol 23 ◽  
pp. xi32-xi33
Author(s):  
D.-W. Kim ◽  
M.-J Ahn ◽  
Y. Shi ◽  
T.M. De Pas ◽  
P.-C Yang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document